User:Danbot/MedicationDose Sandbox

MedicationDose SMW Demo

This page demonstrates the Semantic MediaWiki queries generated by the {{MedicationDose}} template system.

All Medication Doses Across WikEM

 DrugIndicationDoseContextRoutePopulation
Acute pain management#Acetaminophen Step 1 - Mild pain (non-opioid) AdultAcetaminophenAcute pain management650 mg PO q4-6h PRN or 1000 mg PO q6h PRNStep 1 - Mild pain (non-opioid)POAdult
Headache during pregnancy#Acetaminophen First-line analgesic AdultAcetaminophenHeadache during pregnancy1000mg POFirst-line analgesicPOAdult
Volume overload#Acetazolamide ADVOR trial, added to loop diuretic for decongestion AdultAcetazolamideVolume overload500mg IV daily on top of loop diureticADVOR trial, added to loop diuretic for decongestionIVAdult
High altitude cerebral edema#Acetazolamide Adjunctive; better as prophylaxis AdultAcetazolamideHigh altitude cerebral edema250mg BIDAdjunctive; better as prophylaxisPOAdult
Acute mountain sickness#Acetazolamide Moderate-severe AMS AdultAcetazolamideAcute mountain sickness250mg BIDModerate-severe AMSPOAdult
Acute mountain sickness#Acetazolamide Mild AMS; speeds acclimatization via bicarb diuresis AdultAcetazolamideAcute mountain sickness125-250mg BIDMild AMS; speeds acclimatization via bicarb diuresisPOAdult
Idiopathic intracranial hypertension#Acetazolamide Decrease CSF production AdultAcetazolamideIdiopathic intracranial hypertension250mg QID or 500mg BID (titrate up to 500-1000mg QID)Decrease CSF productionPOAdult
Orbital compartment syndrome#Acetazolamide Reduce intraocular pressure AdultAcetazolamideOrbital compartment syndrome250-500mg IVReduce intraocular pressureIVAdult
Retrobulbar hemorrhage#Acetazolamide Reduce intraocular pressure AdultAcetazolamideRetrobulbar hemorrhage250-500mg IVReduce intraocular pressureIVAdult
Herpes Simplex Virus-2#Acyclovir Initial Episode AdultAcyclovir400mg PO q8hrs x 7-10 days or 200mg PO 5x/day x 7-10 daysInitial EpisodeAdult
Bell's palsy#Acyclovir Antiviral AdultAcyclovir400mg 5x per day x1 weekAntiviralAdult
Herpes Simplex Virus-2#Acyclovir Recurrence AdultAcyclovir400mg PO q8hrs x 5 days or 800mg PO q12hrs x 5 days or 800mg PO q8hrs x 2 daysRecurrenceAdult
Pediatric fever of uncertain source#Acyclovir Neonatal 0-28 days if HSV suspected PediatricAcyclovir20mg/kg/doseNeonatal 0-28 days if HSV suspectedPediatric
Encephalitis#Acyclovir Pediatric HSV PediatricAcyclovir20mg/kg IV q8hrs x 21 days (neonates); 10-15mg/kg IV q8hrs x 14-21 days (children)Pediatric HSVPediatric
Encephalitis#Acyclovir HSV AdultAcyclovir10mg/kg (10-15mg/kg for pediatrics) every 8hrsHSVAdult
Herpes Simplex Virus-2#Acyclovir Suppressive AdultAcyclovir400mg PO q12hrs dailySuppressiveAdult
Neonatal conjunctivitis#Acyclovir Herpetic conjunctivitis PediatricAcyclovir20mg/kg IV q8h x 14-21 daysHerpetic conjunctivitisPediatric
Herpes gingivostomatitis#Acyclovir Immunocompromised AdultAcyclovir5 mg/kg IV q8h x 7 daysImmunocompromisedAdult
Herpes gingivostomatitis#Acyclovir Immunocompromised (oral) AdultAcyclovir400mg PO 5x/day x 14-21 daysImmunocompromised (oral)Adult
Herpes labialis#Acyclovir Immunocompromised (oral) AdultAcyclovir400mg PO 5x/day x 14-21 daysImmunocompromised (oral)Adult
Herpes labialis#Acyclovir Immunocompromised AdultAcyclovir5 mg/kg IV q8h x 7 daysImmunocompromisedAdult
Herpes labialis#Acyclovir Normal host PediatricAcyclovir40-80mg/kg PO divided in 3-4 doses for 5-7 daysNormal hostPediatric
Herpes labialis#Acyclovir Normal host AdultAcyclovir400 mg PO 5x/day (q4hrs while awake) x 5 daysNormal hostAdult
Herpes gingivostomatitis#Acyclovir Normal host PediatricAcyclovir40-80mg/kg PO divided in 3-4 doses for 5-7 daysNormal hostPediatric
Herpes gingivostomatitis#Acyclovir Normal host AdultAcyclovir400 mg PO 5x/day (q4hrs while awake) x 5 daysNormal hostAdult
Paroxysmal supraventricular tachycardia#Adenosine 1st line pharmacologic (pediatric) PediatricAdenosineParoxysmal supraventricular tachycardia0.1 mg/kg IV push (1st dose); 0.2 mg/kg IV push (2nd dose)1st line pharmacologic (pediatric)IV pushPediatric
Paroxysmal supraventricular tachycardia#Adenosine 1st line pharmacologic (after vagal maneuvers) AdultAdenosineParoxysmal supraventricular tachycardia6 mg rapid IV push; if no response, 12 mg rapid IV push (may repeat 12 mg x1)1st line pharmacologic (after vagal maneuvers)IV pushAdult
Enterobius#Albendazole Adult AdultAlbendazole400mg PO once then repeat in 2 weeksAdultAdult
Acute diarrhea#Albendazole Microsporidium AdultAlbendazole400mg PO BID x 21 daysMicrosporidiumAdult
Enterobius#Albendazole Pediatric 2 years or older PediatricAlbendazole400mg PO once then repeat in 2 weeksPediatric 2 years or olderPediatric
Enterobius#Albendazole Pediatric under 2 years PediatricAlbendazole200mg PO once then repeat in 2 weeksPediatric under 2 yearsPediatric
Acute asthma exacerbation (peds)#Albuterol First-line bronchodilator PediatricAlbuterolAcute asthma exacerbation (peds)2.5-5mg nebulized q20min x3 (intermittent) or 0.5mg/kg/hr continuous (max 15mg/hr)First-line bronchodilatorNebulizedPediatric
Acute asthma exacerbation#Albuterol Bronchodilator (pediatric) PediatricAlbuterolAcute asthma exacerbation0.15 mg/kg (min 2.5 mg) nebulized q20min x3, then 0.15-0.3 mg/kg q1-4h PRN; or continuous 0.5 mg/kg/hrBronchodilator (pediatric)NebulizedPediatric
Acute asthma exacerbation#Albuterol Bronchodilator (MDI alternative) AdultAlbuterolAcute asthma exacerbation6-12 puffs MDI q20min up to 4h, then q1-4hr PRNBronchodilator (MDI alternative)MDIAdult
Acute asthma exacerbation#Albuterol Bronchodilator (1st line) AdultAlbuterolAcute asthma exacerbation2.5-5 mg nebulized q20min x3, then 2.5-10 mg q1-4hr PRN; or continuous 0.5 mg/kg/hr (max 15 mg/hr)Bronchodilator (1st line)NebulizedAdult
Chloramine#Albuterol Bronchospasm AdultAlbuterolChloramine2.5-5mg nebulized q20min or continuousBronchospasmNebulizedAdult
Tumor lysis syndrome#Allopurinol Xanthine oxidase inhibitor (prevention only) AdultAllopurinolTumor lysis syndrome200-400 mg/m2 q12hr (or 10 mg/kg/day PO divided q8hr)Xanthine oxidase inhibitor (prevention only)IV/POAdult
BenzodiazepinesLorazepam
Chlordiazepoxide
Diazepam
Midazolam
Alprazolam
Flurazepam
Temazepam
Oxazepam
Pulseless arrest#Alteplase PE-related arrest AdultAlteplasePulseless arrest0.6 mg/kg over 15 minPE-related arrestIVAdult
Atrial fibrillation with RVR#Amiodarone Unstable AF; rate/rhythm control when other agents fail AdultAmiodaroneAtrial fibrillation with RVR150mg over 10min, up to 6 dosesUnstable AF; rate/rhythm control when other agents failIVAdult
Junctional tachycardia#Amiodarone First-line antiarrhythmic AdultAmiodaroneJunctional tachycardia2mg/kg bolus, then 10-15mcg/kg/min continuous infusion if neededFirst-line antiarrhythmicIVAdult
Pulseless arrest#Amiodarone 1st line antiarrhythmic AdultAmiodaronePulseless arrest300 mg 1st dose, 150 mg repeat1st line antiarrhythmicIVPAdult
Atrial fibrillation (main)#Amiodarone Rhythm control (if hypotension or advanced HF) AdultAmiodaroneAtrial fibrillation (main)150 mg IV over 10 min, then 1 mg/min x6h, then 0.5 mg/min x18hRhythm control (if hypotension or advanced HF)IV dripAdult
Atrial flutter#Amiodarone Rate control (alternative) AdultAmiodaroneAtrial flutter150 mg over 10 minRate control (alternative)IVAdult
Electrical storm#Amiodarone First-line antiarrhythmic AdultAmiodaroneElectrical storm150mg IV over 10 min, may repeat x1; then 1mg/min x6hr, then 0.5mg/min x18hrFirst-line antiarrhythmicIVAdult
Polymorphic ventricular tachycardia#Amiodarone Non-torsades PMVT, AMI or LV dysfunction AdultAmiodaronePolymorphic ventricular tachycardia150mg IV over 10min, then 1mg/min x6hr, then 0.5mg/min x18hrNon-torsades PMVT, AMI or LV dysfunctionIVAdult
Polymorphic ventricular tachycardia#Amiodarone Non-torsades PMVT PediatricAmiodaronePolymorphic ventricular tachycardia5mg/kg (max 300mg) IV, may repeat x2Non-torsades PMVTIVPediatric
Salmonella#Amoxicillin Salmonella (>3mo) PediatricAmoxicillin50-100mg/kg/day PO divided q8-12h; Acute: x 3-7 days; Acute Immunocompromised: 10-14 days; Chronic: 3 monthsSalmonella (>3mo)Pediatric
Streptococcal pharyngitis#Amoxicillin Penicillin Options AdultAmoxicillin50 mg/kg once daily (maximum = 1000 mg) for 10 daysPenicillin OptionsAdult
Pneumonia (peds)#Amoxicillin Outpatient PediatricAmoxicillin45mg/kg/dose BID x 5-7 days POOutpatientPediatric
Dental abscess#Amoxicillin Dental Abscess AdultAmoxicillin1000mg PO x 1, then 500mg PO q8h x 3 days; If I&DDental AbscessAdult
Pharyngitis#Amoxicillin Strep Pharyngitis PediatricAmoxicillin50mg/kg PO q24h x 10 days'"`UNIQ--ref-0000003F-QINU`"'; Max: 1000mg/dayStrep PharyngitisPediatric
Typhoid fever#Amoxicillin Typhoid Fever AdultAmoxicillinNot 1st line treatment; 50-100mg/kg/day PO divided q6-8h x 14 days; First Dose: 12.5mg-33.3mg/kg PO x 1Typhoid FeverAdult
Typhoid fever#Amoxicillin Typhoid Fever (>3mo) PediatricAmoxicillinNot 1st line treatment; 50-100mg/kg/day PO divided q6-8h x 14 daysTyphoid Fever (>3mo)Pediatric
Chlamydia trachomatis#Amoxicillin Chlamydial Cervicitis/Urethritis AdultAmoxicillin500mg PO q8h x 7 days; For pregnant patientsChlamydial Cervicitis/UrethritisAdult
Helicobacter pylori#Amoxicillin H. pylori PediatricAmoxicillin50mg/kg/day PO divided BID x 7-14 days; Max: 2000mg/dayH. pyloriPediatric
Lyme disease#Amoxicillin Lyme Disease AdultAmoxicillin500mg PO q8h x 14-21 daysLyme DiseaseAdult
Lyme disease#Amoxicillin Early Lyme Disease PediatricAmoxicillin50mg/kg/day PO divided q8h x 14-21 days; First Dose: 16.6mg/kg PO x1; Max: 500mg/doseEarly Lyme DiseasePediatric
Salmonella#Amoxicillin Salmonella AdultAmoxicillinNot 1st line treatment; Acute; Immunocompetent; 500mg PO q8h x 3-7 days; Immunocompromised; 1000mg PO q8h x 3-14 days; Chronic carrier; 1000mg PO q8h x 3 monthsSalmonellaAdult
Sinusitis#Amoxicillin Sinusitis AdultAmoxicillin1000mg PO q8h x 10 daysSinusitisAdult
Sinusitis#Amoxicillin Sinusitis PediatricAmoxicillin90mg/kg/day PO divided q8-12h x 10 days; Max: 1000mg/doseSinusitisPediatric
Streptococcal pharyngitis#Amoxicillin Pediatric First Line PediatricAmoxicillin50mg/kg PO once daily x 10 days (max 1000mg)Pediatric First LinePediatric
Acute otitis media#Amoxicillin Initial, 6-12yr PediatricAmoxicillin80-90mg/kg/day PO divided q12h x 5-10 daysInitial, 6-12yrPediatric
Acute otitis media#Amoxicillin Initial, 2mo-5yr PediatricAmoxicillin80-90mg/kg/day PO divided q12h x 10 daysInitial, 2mo-5yrPediatric
Dental abscess#Amoxicillin Pediatric Outpatient PediatricAmoxicillin50mg/kg/day PO divided TID x 7-10 days (max 1.5g/day)Pediatric OutpatientPediatric
Acute otitis media#Amoxicillin Initial, <2 months PediatricAmoxicillin30mg/kg/day PO divided q12h x 10 daysInitial, <2 monthsPediatric
Periorbital cellulitis#Amoxicillin Outpatient PediatricAmoxicillin45-90 mg/kg per day divided every 12 hoursOutpatientPediatric
Endocarditis#Amoxicillin Dental Procedure Prophylaxis AdultAmoxicillin2g or 50mg/kgDental Procedure ProphylaxisAdult
Periorbital cellulitis#Amoxicillin Outpatient AdultAmoxicillin875 mg BIDOutpatientAdult
Endocarditis#Amoxicillin Pediatric Dental Prophylaxis PediatricAmoxicillin50mg/kg PO (max 2g) 1hr before procedurePediatric Dental ProphylaxisPediatric
Pneumonia (main)#Amoxicillin Outpatient, Healthy AdultAmoxicillin1 g three times dailyOutpatient, HealthyAdult
Suppurative parotitis#Amoxicillin/Clavulanate Pediatric Outpatient PediatricAmoxicillin/Clavulanate45mg/kg/day PO divided BID (max 875mg/dose)Pediatric OutpatientPediatric
Mammalian bites#Amoxicillin/Clavulanate Human bites AdultAmoxicillin/Clavulanate875mg PO BID x 5-7 daysHuman bitesAdult
Diverticulitis#Amoxicillin/Clavulanate Uncomplicated, Preferred AdultAmoxicillin/Clavulanate875/125mg PO Q8hrs x 5 daysUncomplicated, PreferredAdult
Endocarditis#Amoxicillin/Clavulanate Native Valve Endocarditis AdultAmoxicillin/Clavulanate12g/day in 4 dosesNative Valve EndocarditisAdult
Pneumonia (main)#Amoxicillin/Clavulanate Outpatient, Unhealthy AdultAmoxicillin/Clavulanate500 mg/125 mg TID OR amox/clav 875 mg/125 mg BID OR 2,000 mg/125 mg BIDOutpatient, UnhealthyAdult
Acute otitis media#Amoxicillin/Clavulanate Treatment Failure PediatricAmoxicillin/Clavulanate80-90mg of amoxicillin per kg/day PO divided BID x 7-10 daysTreatment FailurePediatric
Erysipelas#Amoxicillin/Clavulanate Treatment Failure AdultAmoxicillin/Clavulanate500mg PO BID x 10 daysTreatment FailureAdult
Dental abscess#Amoxicillin/Clavulanate Pediatric Outpatient PediatricAmoxicillin/Clavulanate25-45mg/kg/day PO divided BID x 7-10 days (max 875mg/dose)Pediatric OutpatientPediatric
Peritonsillar abscess#Amoxicillin/Clavulanate Pediatric Outpatient PediatricAmoxicillin/Clavulanate45mg/kg/day PO divided BID (max 875mg/dose)Pediatric OutpatientPediatric
Acute necrotizing ulcerative gingivitis#Amoxicillin/Clavulanate Uncomplicated AdultAmoxicillin/Clavulanate875 mg PO two times dailyUncomplicatedAdult
Mammalian bites#Amoxicillin/Clavulanate Cat and dog bites AdultAmoxicillin/Clavulanate875mg PO BID x 5-7 daysCat and dog bitesAdult
Mammalian bites#Amoxicillin/Clavulanate Pediatric cat and dog bites PediatricAmoxicillin/Clavulanate25-45mg/kg/day PO divided BID x 5-7 daysPediatric cat and dog bitesPediatric
Mammalian bites#Amoxicillin/Clavulanate Pediatric Human bites PediatricAmoxicillin/Clavulanate25-45mg/kg/day PO divided BID x 5-7 daysPediatric Human bitesPediatric
Neutropenic fever#Amoxicillin/Clavulanate Outpatient with Ciprofloxacin AdultAmoxicillin/Clavulanate875mg PO q12hrs x 7 daysOutpatient with CiprofloxacinAdult
Diabetic foot infection#Amoxicillin/Clavulanate Moderate DFI AdultAmoxicillin/Clavulanate875/125mg PO q12hrsModerate DFIAdult
Impetigo#Amoxicillin/Clavulanate Oral therapy AdultAmoxicillin/Clavulanate875mg (12.5mg/kg) PO q12hrs x 10 daysOral therapyAdult
Impetigo#Amoxicillin/Clavulanate Pediatric Oral PediatricAmoxicillin/Clavulanate25mg/kg/day PO divided BID x 7-10 daysPediatric OralPediatric
Suppurative parotitis#Amoxicillin/Clavulanate Outpatient AdultAmoxicillin/Clavulanate875mg (45mg/kg) PO BIDOutpatientAdult
Mastitis#Amoxicillin/Clavulanate Alternative AdultAmoxicillin/Clavulanate875mg PO q12hrsAlternativeAdult
Peritonsillar abscess#Amoxicillin/Clavulanate Outpatient AdultAmoxicillin/Clavulanate875 mg PO BID x 7-10dOutpatientAdult
Dental abscess#Amoxicillin/Clavulanate Outpatient AdultAmoxicillin/Clavulanate875 mg PO q12 hours x 7-14 daysOutpatientAdult
Cryptococcosis#Amphotericin B Meningitis with AIDS with Flucytosine x 2 weeks AdultAmphotericin B0.7-1mg/kg IV q24hrsMeningitis with AIDS with Flucytosine x 2 weeksAdult
Cryptococcosis#Amphotericin B Meningitis not AIDS with Flucytosine x 4 weeks AdultAmphotericin B0.7-1mg/kg IV q24hrsMeningitis not AIDS with Flucytosine x 4 weeksAdult
Cryptococcosis#Amphotericin B Pediatric Meningitis PediatricAmphotericin B0.7-1mg/kg IV daily x 2-4 weeksPediatric MeningitisPediatric
Pyelonephritis#Ampicillin Pediatric Inpatient PediatricAmpicillin25mg/kg IV q6hrsPediatric InpatientPediatric
Pneumonia (peds)#Ampicillin Newborn hospitalized with Gentamicin PediatricAmpicillin80-90mg/kg/dayNewborn hospitalized with GentamicinPediatric
Pediatric fever of uncertain source#Ampicillin Neonatal 0-14 days PediatricAmpicillin50mg/kg/doseNeonatal 0-14 daysPediatric
Pediatric fever of uncertain source#Ampicillin Neonatal 14-28 days PediatricAmpicillin50mg/kg/doseNeonatal 14-28 daysPediatric
Endocarditis#Ampicillin Dental Procedure Prophylaxis AdultAmpicillin2g (50mg/kg) IV or IMDental Procedure ProphylaxisAdult
Strep. Groups A, B, C, G#Ampicillin Perinatal Group B Streptococcal Prevention AdultAmpicillinInitial 2 g dose at time of labor or rupture of membranes, followed by 1 g q4hrs until deliveryPerinatal Group B Streptococcal PreventionAdult
Endocarditis#Ampicillin Pediatric Dental Prophylaxis PediatricAmpicillin50mg/kg IV/IM (max 2g) 30min before procedurePediatric Dental ProphylaxisPediatric
Endocarditis#Ampicillin Native Valve Endocarditis AdultAmpicillin2g IV six times dailyNative Valve EndocarditisAdult
Pyelonephritis#Ampicillin/Sulbactam UTI, Pyelonephritis AdultAmpicillin/Sulbactam3g IM/IV q6 hours x 14 daysUTI, PyelonephritisAdult
Ludwig's angina#Ampicillin/Sulbactam Immunocompetent AdultAmpicillin/Sulbactam3g (50mg/kg) IV q6 hrsImmunocompetentAdult
Ludwig's angina#Ampicillin/Sulbactam Pediatric Immunocompetent PediatricAmpicillin/Sulbactam50mg/kg IV q6hrs (max 3g/dose)Pediatric ImmunocompetentPediatric
Dental abscess#Ampicillin/Sulbactam Inpatient AdultAmpicillin/Sulbactam3g IV q6 hours x 7 daysInpatientAdult
Mastoiditis#Ampicillin/Sulbactam Pediatric Empiric PediatricAmpicillin/Sulbactam50mg/kg IV q6hrs (max 3g/dose)Pediatric EmpiricPediatric
Mastoiditis#Ampicillin/Sulbactam Empiric AdultAmpicillin/Sulbactam3g (50mg/kg) IV q6 hoursEmpiricAdult
Mammalian bites#Ampicillin/Sulbactam Pediatric Severe PediatricAmpicillin/Sulbactam50mg/kg IV q6hrs (max 3g/dose)Pediatric SeverePediatric
Pelvic inflammatory disease#Ampicillin/Sulbactam Inpatient alternative; combined with Doxycycline AdultAmpicillin/Sulbactam3g IV q6hrInpatient alternative; combined with DoxycyclineAdult
Orbital cellulitis#Ampicillin/Sulbactam Inpatient AdultAmpicillin/Sulbactam3 g IV q6hrInpatientAdult
Postpartum endometritis#Ampicillin/Sulbactam <48hrs postpartum; combined with Doxycycline AdultAmpicillin/Sulbactam3g IV q6hrs<48hrs postpartum; combined with DoxycyclineAdult
Mammalian bites#Ampicillin/Sulbactam Severe mammalian bite infection AdultAmpicillin/Sulbactam3g IV (50mg/kg) q6hrsSevere mammalian bite infectionAdult
Dental abscess#Ampicillin/Sulbactam Pediatric Inpatient PediatricAmpicillin/Sulbactam50mg/kg IV q6hrs (max 3g/dose)Pediatric InpatientPediatric
Endocarditis#Ampicillin/Sulbactam Native Valve Endocarditis AdultAmpicillin/Sulbactam12g/day IV in 4 dosesNative Valve EndocarditisAdult
Pneumonia (main)#Ampicillin-sulbactam Inpatient, CAP Non-ICU AdultAmpicillin/Sulbactam1.5–3g q6hInpatient, CAP Non-ICUAdult
Peritonsillar abscess#Ampicillin/Sulbactam Inpatient AdultAmpicillin/Sulbactam3 gm (75mg/kg) IV four times dailyInpatientAdult
Infectious tenosynovitis#Ampicillin/Sulbactam Animal Bites AdultAmpicillin/Sulbactam3g (50mg/kg) IV four times dailyAnimal BitesAdult
Peritonsillar abscess#Ampicillin/Sulbactam Pediatric Inpatient PediatricAmpicillin/Sulbactam50mg/kg IV q6hrs (max 3g/dose)Pediatric InpatientPediatric
Infectious tenosynovitis#Ampicillin/Sulbactam Pediatrics PediatricAmpicillin/Sulbactam50 mg/kg IV four times dailyPediatricsPediatric
Skin and soft tissue infections#Ampicillin/Sulbactam SSTI PediatricAmpicillin/Sulbactam200mg ampicillin/kg/day IM/IV divided q6 hoursSSTIPediatric
Diabetic foot infection#Ampicillin/Sulbactam Inpatient DFI AdultAmpicillin/Sulbactam3g IV q6hrsInpatient DFIAdult
Orbital cellulitis#Ampicillin/Sulbactam Pediatric Inpatient PediatricAmpicillin/Sulbactam50mg/kg IV q6hrs (max 3g/dose)Pediatric InpatientPediatric
Vasopressors#Angiotensin II Salvage vasopressor AdultAngiotensin IIVasopressors20 ng/kg/min, max 40-80 ng/kg/minSalvage vasopressorIV dripAdult
Pulmonary embolism#Apixaban Anticoagulation (DOAC) AdultApixabanPulmonary embolism10 mg PO BID x1 week, then 5 mg PO BIDAnticoagulation (DOAC)POAdult
Atrial fibrillation (main)#Apixaban Anticoagulation (NOAC) AdultApixabanAtrial fibrillation (main)5 mg BID (reduced: 2.5 mg BID if ≥2 of: age ≥80, wt ≤60 kg, Cr ≥1.5)Anticoagulation (NOAC)POAdult
Transient ischemic attack#Aspirin Antiplatelet, all TIA patients AdultAspirinTransient ischemic attack325mg chewed, then 81mg PO dailyAntiplatelet, all TIA patientsPOAdult
Acute rheumatic fever#Aspirin Anti-inflammatory for carditis/arthritis PediatricAspirinAcute rheumatic fever50-100mg/kg/day PO divided q4-6hAnti-inflammatory for carditis/arthritisPOPediatric
Pericarditis#Aspirin 1st line anti-inflammatory AdultAspirinPericarditis650 mg q6hr x7-10 days, then taper over 3-4 weeks1st line anti-inflammatoryPOAdult
ST-segment elevation myocardial infarction#Aspirin Antiplatelet (immediate) AdultAspirinST-segment elevation myocardial infarction325 mg PO or 600 mg PRAntiplatelet (immediate)PO/PRAdult
Unstable angina#Aspirin Antiplatelet, first-line AdultAspirinUnstable angina325mg chewedAntiplatelet, first-linePOAdult
Non-ST-elevation myocardial infarction#Aspirin Dual antiplatelet therapy; all ACS unless contraindicated AdultAspirinNon-ST-elevation myocardial infarction325mg chewedDual antiplatelet therapy; all ACS unless contraindicatedPOAdult
Acute pain management#Aspirin Step 1 - Mild pain (non-opioid) AdultAspirinAcute pain management650 mg PO q4-6h PRN or 1000 mg PO q6h PRNStep 1 - Mild pain (non-opioid)POAdult
Kawasaki disease#Aspirin Anti-inflammatory/antiplatelet PediatricAspirinKawasaki disease30-100 mg/kg/day divided QID (acute), then 3-5 mg/kg/day (antiplatelet)Anti-inflammatory/antiplateletPOPediatric
Dressler's syndrome#Aspirin NSAID, first-line AdultAspirinDressler's syndrome750-1000mg PO q6-8h, taper by 650-800mg/week over 3-4 weeksNSAID, first-linePOAdult
ST-segment elevation myocardial infarction#Atorvastatin High-intensity statin (start in ED) AdultAtorvastatinST-segment elevation myocardial infarction80 mg POHigh-intensity statin (start in ED)POAdult
Babesiosis#Atovaquone Mild parasitemia less than 4 percent option 1 AdultAtovaquone750mg BID x 10 daysMild parasitemia less than 4 percent option 1Adult
Carbamate poisoning#Atropine Antimuscarinic, first-line PediatricAtropineCarbamate poisoning0.02-0.05mg/kg IV (min 0.1mg), double q5min until drying of secretionsAntimuscarinic, first-lineIVPediatric
Organophosphate toxicity#Atropine 1st line antidote (muscarinic antagonist) AdultAtropineOrganophosphate toxicity1-2 mg IV, then double q5min as needed1st line antidote (muscarinic antagonist)IVAdult
Organophosphate toxicity#Atropine 1st line antidote (muscarinic antagonist) PediatricAtropineOrganophosphate toxicity0.02-0.05 mg/kg (min 0.1 mg)1st line antidote (muscarinic antagonist)IVPediatric
Xylazine#Atropine Symptomatic bradycardia AdultAtropineXylazine0.5-1mg IV, may repeat q3-5min (max 3mg)Symptomatic bradycardiaIVAdult
Clonidine toxicity#Atropine Bradycardia AdultAtropineClonidine toxicity0.5-1 mgBradycardiaIVAdult
Beta-blocker toxicity#Atropine Symptomatic bradycardia (initial) AdultAtropineBeta-blocker toxicity0.5-1 mg IV q3-5min (max 3 mg)Symptomatic bradycardia (initial)IVAdult
Calcium channel blocker toxicity#Atropine Symptomatic bradycardia (pediatric) PediatricAtropineCalcium channel blocker toxicity0.02 mg/kg IV (min 0.1 mg)Symptomatic bradycardia (pediatric)IVPediatric
Calcium channel blocker toxicity#Atropine Symptomatic bradycardia AdultAtropineCalcium channel blocker toxicity0.5-1 mg IV q2-3min (max 3 mg)Symptomatic bradycardiaIVAdult
Rapid sequence intubation#Atropine Premedication PediatricAtropineRapid sequence intubation0.02 mg/kg, no minimum dosePremedicationIVPediatric
Cholinergic crisis#Atropine Antimuscarinic, first-line AdultAtropineCholinergic crisis2-4mg IV q5min, titrate to resolution of bronchorrhea; then infusion at 10% of loading dose/hrAntimuscarinic, first-lineIVAdult
Mushroom toxicity#Atropine Severe cholinergic symptoms (muscarinic mushrooms) AdultAtropineMushroom toxicity0.5-1mg IV (adult); 0.01mg/kg IV (peds)Severe cholinergic symptoms (muscarinic mushrooms)IVAdult
Carbamate poisoning#Atropine Antimuscarinic, first-line AdultAtropineCarbamate poisoning1-2mg IV, double dose q5min until drying of secretionsAntimuscarinic, first-lineIVAdult
Electronic cigarettes#Atropine Cholinergic toxicity antidote (muscarinic) PediatricAtropineElectronic cigarettes0.02-0.05 mg/kg IV (min 0.1 mg), double q5minCholinergic toxicity antidote (muscarinic)IVPediatric
Organophosphate toxicity#Atropine Cholinergic toxicity antidote (muscarinic) AdultAtropineOrganophosphate toxicity1-2 mg IV (double q5min until atropinization)Cholinergic toxicity antidote (muscarinic)IVAdult
Organophosphate toxicity#Atropine Cholinergic toxicity antidote (muscarinic) PediatricAtropineOrganophosphate toxicity0.02-0.05 mg/kg IV (min 0.1 mg), double q5minCholinergic toxicity antidote (muscarinic)IVPediatric
Carbamate toxicity#Atropine Cholinergic toxicity antidote (muscarinic) AdultAtropineCarbamate toxicity1-2 mg IV (double q5min until atropinization)Cholinergic toxicity antidote (muscarinic)IVAdult
Carbamate toxicity#Atropine Cholinergic toxicity antidote (muscarinic) PediatricAtropineCarbamate toxicity0.02-0.05 mg/kg IV (min 0.1 mg), double q5minCholinergic toxicity antidote (muscarinic)IVPediatric
Nicotine toxicity#Atropine Cholinergic toxicity antidote (muscarinic) PediatricAtropineNicotine toxicity0.02-0.05 mg/kg IV (min 0.1 mg), double q5minCholinergic toxicity antidote (muscarinic)IVPediatric
Nicotine toxicity#Atropine Cholinergic toxicity antidote (muscarinic) AdultAtropineNicotine toxicity1-2 mg IV (double q5min until atropinization)Cholinergic toxicity antidote (muscarinic)IVAdult
Electronic cigarettes#Atropine Cholinergic toxicity antidote (muscarinic) AdultAtropineElectronic cigarettes1-2 mg IV (double q5min until atropinization)Cholinergic toxicity antidote (muscarinic)IVAdult
Neonatal conjunctivitis#Azithromycin Chlamydial conjunctivitis PediatricAzithromycin20mg/kg PO once daily x 3 daysChlamydial conjunctivitisPediatric
Traveler's diarrhea#Azithromycin Pediatric travelers diarrhea PediatricAzithromycin10mg/kg/day once daily x 3 daysPediatric travelers diarrheaPediatric
Acute diarrhea#Azithromycin Pediatric travelers diarrhea PediatricAzithromycin10mg/kg/day once daily x 3 daysPediatric travelers diarrheaPediatric
Diarrhea aguda#Azithromycin Pediatric travelers diarrhea PediatricAzithromycin10mg/kg/day once daily x 3 daysPediatric travelers diarrheaPediatric
Acute diarrhea#Azithromycin Pediatric travelers diarrhea PediatricAzithromycin10mg/kg/day once daily x 3 daysPediatric travelers diarrheaPediatric
Mycobacterium avium complex#Azithromycin Primary prophylaxis AdultAzithromycin1200mg PO weekly (Alt: 600mg PO twice weekly)Primary prophylaxisAdult
Mastitis#Azithromycin PCN allergy alternative AdultAzithromycin500mg PO x1 day 1, then 250mg PO daily days 2-5PCN allergy alternativeAdult
Cervicitis#Azithromycin GC/Chlamydia, Pregnant AdultAzithromycin1 g PO x 1GC/Chlamydia, PregnantAdult
Sinusitis#Azithromycin Bacterial sinusitis PediatricAzithromycinChildren ≥6 months: Oral: 10mg/kg PO once daily for 3 days (maximum: 500mg daily)Bacterial sinusitisPediatric
Acute diarrhea#Azithromycin Campylobacter AdultAzithromycin500mg PO once daily x 5 daysCampylobacterAdult
Mycobacterium avium complex#Azithromycin Secondary prophylaxis AdultAzithromycin500-600mg PO daily (use with ethambutol; not 1st-line)Secondary prophylaxisAdult
Pertussis#Azithromycin Adults AdultAzithromycin500mg PO once daily for day #1 then 250mg PO once daily for days #2-5AdultsAdult
Mycobacterium avium complex#Azithromycin Treatment, disseminated AdultAzithromycin500-600mg PO daily (use with ethambutol; not 1st-line)Treatment, disseminatedAdult
Pneumonia (main)#Azithromycin Outpatient, Unhealthy AdultAzithromycin500 mg on first day then 250 mg dailyOutpatient, UnhealthyAdult
Pneumonia (main)#Azithromycin Inpatient, CAP Non-ICU AdultAzithromycin500 mg dailyInpatient, CAP Non-ICUAdult
COPD exacerbation#Azithromycin COPD exacerbation AdultAzithromycin500mg PO x1 on day 1, then 250mg PO q24h x4 days; Alt: 500mg PO q24h x3 daysCOPD exacerbationAdult
Urethritis in men#Azithromycin Urethritis, non-gonococcal initial infection AdultAzithromycin1 g PO x1Urethritis, non-gonococcal initial infectionAdult
Chancroid#Azithromycin Chancroid AdultAzithromycin1 g PO x1ChancroidAdult
Streptococcal pharyngitis#Azithromycin Pediatric PCN Allergy (severe) PediatricAzithromycin12mg/kg PO day 1 (max 500mg), then 6mg/kg daily x 4 days (max 250mg)Pediatric PCN Allergy (severe)Pediatric
Gonorrheal conjunctivitis#Azithromycin Chlamydial Conjunctivitis AdultAzithromycin1g (20mg/kg) PO one time doseChlamydial ConjunctivitisAdult
Gonorrheal conjunctivitis#Azithromycin Chlamydial Conjunctivitis, Newborn PediatricAzithromycin20mg/kg PO once daily x 3 daysChlamydial Conjunctivitis, NewbornPediatric
Gonorrheal conjunctivitis#Azithromycin Gonococcal Conjunctivitis AdultAzithromycin1g PO one doseGonococcal ConjunctivitisAdult
Typhoid fever#Azithromycin Quinolone Resistant, Oral AdultAzithromycin1 g PO daily x 5 daysQuinolone Resistant, OralAdult
Pharyngitis#Azithromycin Pharyngitis (as an alternative agent in penicillin allergic patients) PediatricAzithromycinChildren ≥2 years and Adolescents: Oral: 12mg/kg/dose once daily for 5 days (maximum: 500mg daily)Pharyngitis (as an alternative agent in penicillin allergic patients)Pediatric
Pelvic inflammatory disease#Azithromycin PID AdultAzithromycin500mg IV q24h x1-2 days, then 250mg PO q24h x5-6 daysPIDAdult
Streptococcal pharyngitis#Azithromycin Penicillin Allergy (anaphylaxis) AdultAzithromycin12 mg/kg PO once (maximum = 500 mg), then 6 mg/kg (max=250 mg) once daily for the next 4 daysPenicillin Allergy (anaphylaxis)Adult
Acute diarrhea#Azithromycin Shigella AdultAzithromycin500mg PO daily x 5 daysShigellaAdult
Acute otitis media#Azithromycin Penicillin Allergy PediatricAzithromycin10mg/kg/day x 1 day and 5mg/kg/day x 4 remaining daysPenicillin AllergyPediatric
Acute diarrhea#Azithromycin Vibrio cholerae AdultAzithromycin20mg/kg (1g) PO onceVibrio choleraeAdult
Traveler's diarrhea#Azithromycin Traveler's Diarrhea AdultAzithromycin500mg PO q24h x 3 days OR 1000mg PO x 1Traveler's DiarrheaAdult
Salmonella#Azithromycin Salmonella AdultAzithromycin1 g PO q24h x1 day, then 500mg PO q24h x2-6 daysSalmonellaAdult
Pneumonia (main)#Azithromycin Outpatient, Healthy AdultAzithromycin500 mg on first day then 250 mg dailyOutpatient, HealthyAdult
Acute diarrhea#Azithromycin Pediatric Shigella PediatricAzithromycin10mg/kg PO day 1 (max 500mg), then 5mg/kg/day x 4 daysPediatric ShigellaPediatric
Typhoid fever#Azithromycin Pediatric, Oral PediatricAzithromycin10-20mg/kg PO daily x 5-7 days (max 1g)Pediatric, OralPediatric
Acute diarrhea#Azithromycin Pediatric Salmonella PediatricAzithromycin10mg/kg PO day 1, then 5mg/kg/day x 4 daysPediatric SalmonellaPediatric
Lymphogranuloma venereum#Azithromycin Pregnancy Alternative AdultAzithromycin1g PO weekly for 3 weeksPregnancy AlternativeAdult
Bacterial conjunctivitis#Azithromycin Pediatric PediatricAzithromycin1% ophthalmic solution 1 drop BID x 2 days then daily x 5 daysPediatricPediatric
Acute diarrhea#Azithromycin Pediatric Campylobacter PediatricAzithromycin10mg/kg PO daily x 3 days (max 500mg)Pediatric CampylobacterPediatric
Endocarditis#Azithromycin Dental Procedure Prophylaxis AdultAzithromycin500mg (15mg/kg) PODental Procedure ProphylaxisAdult
Bacterial conjunctivitis#Azithromycin Bacterial Conjunctivitis, Topical AdultAzithromycin1% ophthalmic solution 1 drop BID for 2 days THEN 1 drop daily for 5 daysBacterial Conjunctivitis, TopicalAdult
Endocarditis#Azithromycin Pediatric Dental Prophylaxis, PCN Allergy PediatricAzithromycin15mg/kg PO (max 500mg)Pediatric Dental Prophylaxis, PCN AllergyPediatric
Pneumonia (peds)#Azithromycin 1-3 month afebrile pneumonitis PediatricAzithromycin2.5mg/kg q12hrs1-3 month afebrile pneumonitisPediatric
Pneumonia (main)#Azithromycin ICU, Low Risk AdultAzithromycin500mg IVICU, Low RiskAdult
Pneumonia (main)#Azithromycin ICU, Risk of Pseudomonas AdultAzithromycin500mg IV dailyICU, Risk of PseudomonasAdult
Babesiosis#Azithromycin Mild parasitemia less than 4 percent option 1 with Atovaquone AdultAzithromycin500-1000mg day 1 then 250-1000mg daily x 10 daysMild parasitemia less than 4 percent option 1 with AtovaquoneAdult
Infectious tenosynovitis#Azithromycin Gonococcal AdultAzithromycin1g PO onceGonococcalAdult
Toxoplasmosis#Azithromycin Immunosuppressed alt AdultAzithromycin1200mg PO q24hrsImmunosuppressed altAdult
Pertussis#Azithromycin <1 month old PediatricAzithromycin10mg/kg (max 500mg/day) daily x 5 days<1 month oldPediatric
Pertussis#Azithromycin >1 month old PediatricAzithromycin10mg/kg (max 500mg/day) daily x 5 days>1 month oldPediatric
Open fracture#Aztreonam Pediatric Grade III, allergy PediatricAztreonam30mg/kg IV (max 2g) then q8hrs x 3Pediatric Grade III, allergyPediatric
Pneumonia (main)#Aztreonam VAP, High Risk AdultAztreonam2g q8hVAP, High RiskAdult
Peritonitis#Aztreonam Allergy/Prior exposure AdultAztreonam2g (30mg/kg) IV q8hrsAllergy/Prior exposureAdult
Diabetic foot infection#Aztreonam Inpatient DFI AdultAztreonam2g IV q8hrsInpatient DFIAdult
Open fracture#Aztreonam Grade III, Cephalosporin allergy AdultAztreonam2 g IV (immediately and q8 hours x 3)Grade III, Cephalosporin allergyAdult
Pneumonia (main)#Aztreonam ICU, Low Risk (PCN allergy) AdultAztreonam1-2g IVICU, Low Risk (PCN allergy)Adult
Extrapyramidal reaction#Benztropine Anticholinergic for acute dystonia/akathisia AdultBenztropineExtrapyramidal reaction1-2mg PO or IV/IMAnticholinergic for acute dystonia/akathisiaPO/IV/IMAdult
Dystonic reaction#Benztropine Anticholinergic, first-line AdultBenztropineDystonic reaction1-2mg IV over 2 minAnticholinergic, first-lineIVAdult
Antipsychotic toxicity#Benztropine Dystonic reaction, alternative AdultBenztropineAntipsychotic toxicity1-2mg IV/IMDystonic reaction, alternativeIV/IMAdult
Akathisia#Benztropine Anticholinergic, first-line AdultBenztropineAkathisia1-2mg IVAnticholinergic, first-lineIVAdult
Preterm labor#Betamethasone Fetal lung maturity (24-34 weeks gestation) AdultBetamethasonePreterm labor12mg IM q24hr x 2 dosesFetal lung maturity (24-34 weeks gestation)IMAdult
ST-segment elevation myocardial infarction#Bivalirudin Anticoagulation (direct thrombin inhibitor) AdultBivalirudinST-segment elevation myocardial infarction0.75 mg/kg IV bolus, then 1.75 mg/kg/hr dripAnticoagulation (direct thrombin inhibitor)IV dripAdult
Volume overload#Bumetanide Loop diuretic alternative AdultBumetanideVolume overload1-2mg IV (equivalent to furosemide 40-80mg)Loop diuretic alternativeIVAdult
Loop diureticFurosemide
Bumetanide
Torsemide
Ethacrynic acid
Opioid toxicity#Buprenorphine ED-initiated buprenorphine for OUD AdultBuprenorphineOpioid toxicity4 mg SL initial; may give additional 4 mg SL after 1-2 hours (total 8-16 mg on day 1)ED-initiated buprenorphine for OUDSLAdult
Neonatal abstinence syndrome#Buprenorphine Alternative to morphine; may reduce hospital stay PediatricBuprenorphineNeonatal abstinence syndrome5mcg/kg q8hr initially (max 20mcg/kg q8hr)Alternative to morphine; may reduce hospital staySublingualPediatric
Acute pain management#Butorphanol Step 3 - Severe pain (mixed agonist-antagonist) AdultButorphanolAcute pain management0.5-2.0 mg IV; average 2 mg q3-4hStep 3 - Severe pain (mixed agonist-antagonist)IVAdult
Post-lumbar puncture headache#Caffeine Conservative management before blood patch AdultCaffeinePost-lumbar puncture headache300mg PO x1, or 500mg IV in 1L NS over 1hrConservative management before blood patchPO/IVAdult
Hypercalcemia#Calcitonin Symptomatic or severe hypercalcemia (Ca >14 mg/dL) AdultCalcitoninHypercalcemia4 units/kg q12hrSymptomatic or severe hypercalcemia (Ca >14 mg/dL)SC or IVAdult
Beta-blocker toxicity#Calcium chloride Calcium supplementation AdultCalcium chlorideBeta-blocker toxicity1-3 g IV (10-20 mL 10% solution)Calcium supplementationIVAdult
Calcium channel blocker toxicity#Calcium chloride Calcium supplementation (preferred, 3x calcium vs gluconate) AdultCalcium chlorideCalcium channel blocker toxicity1-3 g IV bolus (10-20 mL 10% solution), then 1 g IV q5min to BP effect; drip 10-50 mg/kg/hrCalcium supplementation (preferred, 3x calcium vs gluconate)IV/IV dripAdult
Hypermagnesemia#Calcium chloride Antagonize cardiac/respiratory effects of hypermagnesemia AdultCalcium chlorideHypermagnesemia5-10mL of 10% solutionAntagonize cardiac/respiratory effects of hypermagnesemiaIVAdult
Hypocalcemia#Calcium chloride Symptomatic hypocalcemia (alternative to calcium gluconate) AdultCalcium chlorideHypocalcemia10mL of 10% solutionSymptomatic hypocalcemia (alternative to calcium gluconate)IVAdult
Calcium channel blocker toxicity#Calcium gluconate Calcium supplementation AdultCalcium gluconateCalcium channel blocker toxicity3 g (30-60 mL of 10% solution) IV bolusCalcium supplementationIVAdult
Hypermagnesemia#Calcium gluconate Antagonize cardiac/respiratory effects of hypermagnesemia (alternative to calcium chloride) AdultCalcium gluconateHypermagnesemia15-30mL of 10% solutionAntagonize cardiac/respiratory effects of hypermagnesemia (alternative to calcium chloride)IVAdult
Hydrofluoric acid#Calcium gluconate Minor cutaneous burns (<50 cm2 from <20% solutions) AdultCalcium gluconateHydrofluoric acidTopical gel (3.5g powder in 150mL lubricant or 25mL 10% soln in 75mL lubricant)Minor cutaneous burns (<50 cm2 from <20% solutions)TopicalAdult
Tumor lysis syndrome#Calcium gluconate Symptomatic hypocalcemia AdultCalcium gluconateTumor lysis syndrome50-200 mgSymptomatic hypocalcemiaIVAdult
Hydrofluoric acid#Calcium gluconate Severe cutaneous burns AdultCalcium gluconateHydrofluoric acid5% intradermal injection (max 0.5mL/cm2)Severe cutaneous burnsIntradermalAdult
Hypocalcemia#Calcium gluconate Asymptomatic hypocalcemia AdultCalcium gluconateHypocalcemia1g PO Q6hrsAsymptomatic hypocalcemiaPOAdult
Hypocalcemia#Calcium gluconate Symptomatic hypocalcemia AdultCalcium gluconateHypocalcemia10mL of 10% solutionSymptomatic hypocalcemiaIVAdult
Hydrofluoric acid#Calcium gluconate Refractory cutaneous burns AdultCalcium gluconateHydrofluoric acid10mL of 10% in 40mL NS via Bier block (20min dwell time)Refractory cutaneous burnsIV regional (Bier block)Adult
Hydrogen fluoride toxicity#Calcium gluconate Systemic HF exposure, correct hypocalcemia AdultCalcium gluconateHydrogen fluoride toxicity100mg IV (10mL of 10% solution) over 2-3 minSystemic HF exposure, correct hypocalcemiaIVAdult
Seizure (peds)#Calcium gluconate Hypocalcemic seizure PediatricCalcium gluconateSeizure (peds)0.3mL/kg of 10% solution over 5-10minHypocalcemic seizureIVPediatric
Ethanol withdrawal#Carbamazepine Outpatient anticonvulsant alternative AdultCarbamazepineEthanol withdrawal200 mg QID (days 1-3), taper to 200 mg QHS (days 10-11)Outpatient anticonvulsant alternativePOAdult
Streptococcal pharyngitis#Cefadroxil Pediatric PCN Allergy PediatricCefadroxil30mg/kg PO daily x 10 days (max 1g)Pediatric PCN AllergyPediatric
Streptococcal pharyngitis#Cefadroxil Penicillin Allergy (mild) AdultCefadroxil30 mg per kg PO QD (maximum 1 g daily) x 10 daysPenicillin Allergy (mild)Adult
Peritonitis#Cefazolin Primary AdultCefazolin1g (30mg/kg) IV q8hrsPrimaryAdult
Endocarditis#Cefazolin Dental Procedure Prophylaxis AdultCefazolin1g (50mg/kg) IM or IVDental Procedure ProphylaxisAdult
Open fracture#Cefazolin Grade I & II Fractures AdultCefazolin2 g IV (immediately and q8 hours x 3 total doses)Grade I & II FracturesAdult
Open fracture#Cefazolin Pediatric Grade I & II PediatricCefazolin25mg/kg IV (max 2g) immediately then q8hrs x 3 dosesPediatric Grade I & IIPediatric
Acute otitis media#Cefdinir Prior Month Treatment PediatricCefdinir14mg/kg/day BID x7-10 daysPrior Month TreatmentPediatric
Pyelonephritis#Cefdinir Outpatient AdultCefdinir300mg BID PO x 10-14 daysOutpatientAdult
Periorbital cellulitis#Cefdinir Outpatient PediatricCefdinir14 mg/kg per day, divided every 12 hours, max daily 600 mgOutpatientPediatric
Pyelonephritis#Cefdinir Pediatric Outpatient PediatricCefdinir14mg/kg/day PO divided BID x 10 days (max 600mg/day)Pediatric OutpatientPediatric
Periorbital cellulitis#Cefdinir Outpatient AdultCefdinir300 mg BIDOutpatientAdult
Pneumonia (main)#Cefepime VAP, High Risk AdultCefepime2g q8hVAP, High RiskAdult
Neutropenic fever#Cefepime Inpatient monotherapy AdultCefepime2g IV q8hrsInpatient monotherapyAdult
Cystic fibrosis#Cefepime Respiratory Infections, cystic fibrosis patients PediatricCefepime>2 mo: Dose: 50mg/kg IV q8h x2wk; Max: 2 g/doseRespiratory Infections, cystic fibrosis patientsPediatric
Pediatric fever of uncertain source#Cefepime Neonatal 0-14 days with Ampicillin PediatricCefepime30mg/kg/doseNeonatal 0-14 days with AmpicillinPediatric
Pneumonia (peds)#Cefepime Hospitalized PICU severely ill PediatricCefepime50mg/kg/dose q8hrs IVHospitalized PICU severely illPediatric
Pyelonephritis#Cefepime Adult Inpatient AdultCefepime2gm IV q8hrAdult InpatientAdult
Acute cystitis#Cefepime Inpatient AdultCefepime2gm IV q8hrInpatientAdult
Discitis#Cefepime Inpatient Therapy AdultCefepime2g IV three times dailyInpatient TherapyAdult
Ludwig's angina#Cefepime Immunocompromised AdultCefepime2 g IV q12 hrsImmunocompromisedAdult
Peritonitis#Cefepime Allergy/Prior exposure AdultCefepime2g IV once dailyAllergy/Prior exposureAdult
Diabetic foot infection#Cefepime Inpatient DFI AdultCefepime2g IV q12hrsInpatient DFIAdult
Pneumonia (main)#Cefepime HAP, High Risk AdultCefepime2g q8hHAP, High RiskAdult
Pneumonia (main)#Cefepime ICU, Risk of Pseudomonas AdultCefepime2g q8hICU, Risk of PseudomonasAdult
Neutropenic fever#Cefepime Pediatric Inpatient PediatricCefepime50mg/kg IV q8hrs (max 2g)Pediatric InpatientPediatric
Ludwig's angina#Cefepime Pediatric Immunocompromised PediatricCefepime50mg/kg IV q8hrs (max 2g)Pediatric ImmunocompromisedPediatric
Typhoid fever#Cefixime Pediatric Oral Step-down PediatricCefixime15-20mg/kg/day PO divided BID x 7-14 days (max 400mg/dose)Pediatric Oral Step-downPediatric
Urethritis in men#Cefixime CTX Contraindicated AdultCefixime800 mg PO x 1CTX ContraindicatedAdult
Typhoid fever#Cefixime Quinolone Resistant, Parenteral AdultCefixime10-15 mg/kg IV q 12 hrs x 8 daysQuinolone Resistant, ParenteralAdult
Cervicitis#Cefixime GC/Chlamydia, CTX Contraindicated AdultCefixime800 mg PO x 1GC/Chlamydia, CTX ContraindicatedAdult
Acute cystitis#Cefixime Pediatric PediatricCefixime8mg/kg/day PO daily (max 400mg)PediatricPediatric
Pyelonephritis#Cefixime Outpatient AdultCefixime400mg PO daily x 10 daysOutpatientAdult
Pyelonephritis#Cefixime Pediatric Outpatient PediatricCefixime8mg/kg PO daily x 10-14 days (max 400mg)Pediatric OutpatientPediatric
Pyelonephritis#Cefotaxime Adult Inpatient AdultCefotaxime1-2gm IV q8hrAdult InpatientAdult
Brain abscess#Cefotaxime Pediatric Empiric PediatricCefotaxime50mg/kg IV q6hrs (max 2g/dose)Pediatric EmpiricPediatric
Acute cystitis#Cefotaxime Inpatient AdultCefotaxime1-2gm IV q8hrInpatientAdult
Acute cystitis#Cefotaxime Pediatric Inpatient PediatricCefotaxime50mg/kg IV q8hrs (max 2g/dose)Pediatric InpatientPediatric
Orbital cellulitis#Cefotaxime Inpatient AdultCefotaxime2 g IV q4hInpatientAdult
Orbital cellulitis#Cefotaxime Pediatric Inpatient PediatricCefotaxime50mg/kg IV q6hrs (max 2g/dose)Pediatric InpatientPediatric
Ventriculoperitoneal shunt infection#Cefotaxime Empiric with Vancomycin PediatricCefotaxime200mg/kg/day IV div q6hrsEmpiric with VancomycinPediatric
Pyelonephritis#Cefotaxime Pediatric Inpatient PediatricCefotaxime50mg/kg IV q8hrsPediatric InpatientPediatric
Peritonitis#Cefotaxime Pediatric PediatricCefotaxime50mg/kg IV q8hrs (max 2g/dose)PediatricPediatric
Pneumonia (peds)#Cefotaxime 1-3 month febrile pneumonia PediatricCefotaxime200mg/kg/day div q8hrs1-3 month febrile pneumoniaPediatric
Osteomyelitis#Cefotaxime Sickle Cell Disease PediatricCefotaxime50mg/kg IV three times dailySickle Cell DiseasePediatric
Pneumonia (main)#Cefotaxime Inpatient, CAP Non-ICU AdultCefotaxime1–2g q8hInpatient, CAP Non-ICUAdult
Brain abscess#Cefotaxime Otogenic AdultCefotaxime2gm IV q6hrOtogenicAdult
Neonatal conjunctivitis#Cefotaxime Gonococcal conjunctivitis PediatricCefotaxime100mg/kg IV or IM x1Gonococcal conjunctivitisPediatric
Pelvic inflammatory disease#Cefotetan Inpatient AdultCefotetan2g IV q12hrInpatientAdult
Acute cystitis#Cefotetan UTI, uncomplicated AdultCefotetan500 mg IM/IV q12hUTI, uncomplicatedAdult
Postpartum endometritis#Cefoxitin <48hrs postpartum; combined with Doxycycline AdultCefoxitin2g IV q6hrs<48hrs postpartum; combined with DoxycyclineAdult
Mammalian bites#Cefoxitin Severe mammalian bite infection AdultCefoxitin1g IV q8hrs (25mg/kg q6hrs)Severe mammalian bite infectionAdult
Pelvic inflammatory disease#Cefoxitin Inpatient AdultCefoxitin2g IV q6hrInpatientAdult
Pelvic inflammatory disease#Cefoxitin Outpatient alternative AdultCefoxitin2g IM x1 plus Probenecid 1g POOutpatient alternativeAdult
Acute cystitis#Cefpodoxime Pediatric PediatricCefpodoxime10mg/kg/day PO divided BID (max 200mg/dose)PediatricPediatric
Acute otitis media#Cefpodoxime Prior Month Treatment PediatricCefpodoxime10mg/kg PO daily x7-10 daysPrior Month TreatmentPediatric
Sinusitis#Cefpodoxime Acute sinusitis PediatricCefpodoxime5mg/kg/dose (max 200mg/dose) q12h x 10 daysAcute sinusitisPediatric
Pyelonephritis#Cefpodoxime Outpatient AdultCefpodoxime200mg PO BID x 10 daysOutpatientAdult
Pyelonephritis#Cefpodoxime Pediatric Outpatient PediatricCefpodoxime10mg/kg/day PO divided BID x 10 days (max 200mg/dose)Pediatric OutpatientPediatric
Acute cystitis#Cefpodoxime Outpatient, Women Complicated AdultCefpodoxime200 mg BID x10-14dOutpatient, Women ComplicatedAdult
Pneumonia (main)#Cefpodoxime Outpatient, Unhealthy AdultCefpodoxime200 mg BIDOutpatient, UnhealthyAdult
COPD exacerbation#Cefpodoxime Bronchitis (chronic) AdultCefpodoxime200mg q 12 h for 10 daysBronchitis (chronic)Adult
Skin and soft tissue infections#Cefpodoxime Skin and soft tissue infection AdultCefpodoxime400mg q 12 h for 14 daysSkin and soft tissue infectionAdult
Pharyngitis#Cefpodoxime Pharyngitis/Tonsillitis AdultCefpodoxime100mg q 12 h for 5-10 daysPharyngitis/TonsillitisAdult
Periorbital cellulitis#Cefpodoxime Outpatient PediatricCefpodoxime10 mg/kg per day divided every 12 hours, max 200 mgOutpatientPediatric
Periorbital cellulitis#Cefpodoxime Outpatient AdultCefpodoxime400mg BIDOutpatientAdult
Acute cystitis#Cefpodoxime Men AdultCefpodoxime200 mg BID x10-14dMenAdult
Acute otitis media#Cefprozil Prior Month Treatment PediatricCefprozil15mg/kg PO BID x7-10 daysPrior Month TreatmentPediatric
Pneumonia (main)#Ceftaroline Inpatient, CAP Non-ICU AdultCeftaroline600mg q12hInpatient, CAP Non-ICUAdult
Brain abscess#Ceftazidime Trauma/Post-surgical AdultCeftazidime2gm IV q8hrTrauma/Post-surgicalAdult
Osteomyelitis#Ceftazidime Newborn PediatricCeftazidime30mg/kg IV q12 hNewbornPediatric
Discitis#Ceftazidime Inpatient Therapy AdultCeftazidime2g IV three times dailyInpatient TherapyAdult
Osteomyelitis#Ceftazidime Children PediatricCeftazidime50mg/kg q8hrChildrenPediatric
Peritoneal dialysis-associated peritonitis#Ceftazidime Empiric IP AdultCeftazidime1g IP dailyEmpiric IPAdult
Pneumonia (main)#Ceftazidime HAP, High Risk AdultCeftazidime2g q8hHAP, High RiskAdult
Brain abscess#Ceftazidime Pediatric Trauma/Post-surgical PediatricCeftazidime50mg/kg IV q8hrs (max 2g/dose)Pediatric Trauma/Post-surgicalPediatric
Neutropenic fever#Ceftazidime Inpatient monotherapy AdultCeftazidime2g IV q8hrsInpatient monotherapyAdult
Prostatitis#Ceftriaxone Septic AdultCeftriaxone1g IV q12hrsSepticAdult
Prostatitis#Ceftriaxone STD Associated AdultCeftriaxone500mg IM x1STD AssociatedAdult
Mastoiditis#Ceftriaxone Pediatric Empiric PediatricCeftriaxone50mg/kg IV daily (max 2g)Pediatric EmpiricPediatric
Sinusitis#Ceftriaxone Pediatric Sinusitis, Severe PediatricCeftriaxone50mg/kg IV daily (max 2g); for severe or treatment failurePediatric Sinusitis, SeverePediatric
Epidural abscess (spinal)#Ceftriaxone Empiric AdultCeftriaxonestandard dosingEmpiricAdult
Gonorrheal conjunctivitis#Ceftriaxone Gonococcal Conjunctivitis AdultCeftriaxone1g IM single doseGonococcal ConjunctivitisAdult
Gonorrheal conjunctivitis#Ceftriaxone Gonococcal Conjunctivitis, Newborn PediatricCeftriaxone25-50mg IV or IM, max 125mgGonococcal Conjunctivitis, NewbornPediatric
Pelvic inflammatory disease#Ceftriaxone Inpatient; combined with Doxycycline and Metronidazole AdultCeftriaxone1g IV q24hrInpatient; combined with Doxycycline and MetronidazoleAdult
Pyelonephritis#Ceftriaxone Adult Inpatient AdultCeftriaxone1gm IV QDAdult InpatientAdult
Orbital cellulitis#Ceftriaxone Pediatric Inpatient PediatricCeftriaxone50mg/kg IV q12hrs (max 2g/dose)Pediatric InpatientPediatric
Pelvic inflammatory disease#Ceftriaxone Outpatient; combined with Doxycycline and Metronidazole AdultCeftriaxone500mg IM x1 (1g if >150kg)Outpatient; combined with Doxycycline and MetronidazoleAdult
Ventriculoperitoneal shunt infection#Ceftriaxone Empiric with Vancomycin PediatricCeftriaxone100mg/kg/day IV div q12-24hrsEmpiric with VancomycinPediatric
Mastoiditis#Ceftriaxone Empiric AdultCeftriaxone1g (50mg/kg) IV once dailyEmpiricAdult
Pyelonephritis#Ceftriaxone Pediatric Inpatient PediatricCeftriaxone75mg/kg IV QDPediatric InpatientPediatric
Open fracture#Ceftriaxone Pediatric Grade III PediatricCeftriaxone50mg/kg IV (max 2g) x 1Pediatric Grade IIIPediatric
Peritonitis#Ceftriaxone Pediatric PediatricCeftriaxone50-75mg/kg IV daily (max 2g)PediatricPediatric
Pneumonia (peds)#Ceftriaxone Hospitalized moderately ill not fully immunized PediatricCeftriaxone50mg/kg/day q24hrs IV (max 2g/dose)Hospitalized moderately ill not fully immunizedPediatric
Epidural abscess (spinal)#Ceftriaxone Pediatric Empiric PediatricCeftriaxone50-75mg/kg IV daily (max 2g)Pediatric EmpiricPediatric
Pneumonia (main)#Ceftriaxone Inpatient, CAP Non-ICU AdultCeftriaxone1–2g dailyInpatient, CAP Non-ICUAdult
Pediatric fever of uncertain source#Ceftriaxone 90 days to 36 months PediatricCeftriaxone50-100mg/kg/dose90 days to 36 monthsPediatric
Syphilis#Ceftriaxone Neurosyphilis, Alternative AdultCeftriaxone2gm IV once daily for 10-14 daysNeurosyphilis, AlternativeAdult
Osteomyelitis#Ceftriaxone Sickle Cell Disease PediatricCeftriaxone50mg/kg IV once dailySickle Cell DiseasePediatric
Pediatric fever of uncertain source#Ceftriaxone Neonatal 14-28 days with Ampicillin PediatricCeftriaxone50-100mg/kg/doseNeonatal 14-28 days with AmpicillinPediatric
Urethritis in men#Ceftriaxone Uncomplicated, Gonorrhea AdultCeftriaxoneIM x 1 (500mg if <150kg, 1g if ≥150kg)Uncomplicated, GonorrheaAdult
Sinusitis#Ceftriaxone Sinusitis, Severe AdultCeftriaxone1-2g IV q12-24h x 7-10 daysSinusitis, SevereAdult
Peritonitis#Ceftriaxone Primary AdultCeftriaxone1g IV once dailyPrimaryAdult
Infectious tenosynovitis#Ceftriaxone Pediatrics PediatricCeftriaxone100mg/kg IV once dailyPediatricsPediatric
Infectious tenosynovitis#Ceftriaxone Empiric AdultCeftriaxone1g IV dailyEmpiricAdult
Surgical prophylaxis#Ceftriaxone Surgical prophylaxis AdultCeftriaxone2g IV within 60 minutes of incisionSurgical prophylaxisAdult
Acute otitis media#Ceftriaxone Treatment Failure PediatricCeftriaxone50mg/kg IM once as single injection x 3 daysTreatment FailurePediatric
Acute cystitis#Ceftriaxone Urethritis Concern AdultCeftriaxone250mg IM x1Urethritis ConcernAdult
Acute diarrhea#Ceftriaxone Salmonella AdultCeftriaxone2g IV once daily x 5 daysSalmonellaAdult
Orbital cellulitis#Ceftriaxone Inpatient AdultCeftriaxone2 g IV q12hrInpatientAdult
Erysipelas#Ceftriaxone Pediatric Inpatient PediatricCeftriaxone50mg/kg IV daily (max 2g) x 10 daysPediatric InpatientPediatric
Open fracture#Ceftriaxone Grade III Fractures AdultCeftriaxone2 g IV (immediately x 1 total dose)Grade III FracturesAdult
Discitis#Ceftriaxone Inpatient Therapy AdultCeftriaxone2g IV dailyInpatient TherapyAdult
Epididymitis#Ceftriaxone STI AdultCeftriaxone500 mg IM in a single doseSTIAdult
Acute cystitis#Ceftriaxone Pediatric Inpatient PediatricCeftriaxone50-75mg/kg IV daily (max 2g)Pediatric InpatientPediatric
Pneumonia (main)#Ceftriaxone ICU, Low Risk AdultCeftriaxone1-2g IVICU, Low RiskAdult
Endocarditis#Ceftriaxone Pediatric Empiric PediatricCeftriaxone100mg/kg/day IV divided q12h (max 4g/day)Pediatric EmpiricPediatric
Typhoid fever#Ceftriaxone Quinolone Resistant, Parenteral AdultCeftriaxone2g IV q 24 hrs x 14 daysQuinolone Resistant, ParenteralAdult
Endocarditis#Ceftriaxone Dental Procedure Prophylaxis AdultCeftriaxone1g (50mg/kg) IM or IVDental Procedure ProphylaxisAdult
Acute diarrhea#Ceftriaxone Pediatric Salmonella PediatricCeftriaxone50-75mg/kg IV daily x 5 days (max 2g)Pediatric SalmonellaPediatric
Acute diarrhea#Ceftriaxone Pediatric Shigella Severe PediatricCeftriaxone50mg/kg IM/IV daily x 5 days (max 2g)Pediatric Shigella SeverePediatric
Cervicitis#Ceftriaxone GC/Chlamydia, Standard AdultCeftriaxoneIM x 1 (500mg if <150kg, 1g if ≥150kg)GC/Chlamydia, StandardAdult
Mammalian bites#Ceftriaxone Severe mammalian bite infection AdultCeftriaxone1g (50mg/kg) IV onceSevere mammalian bite infectionAdult
Mammalian bites#Ceftriaxone Pediatric Severe PediatricCeftriaxone50mg/kg IV daily (max 2g)Pediatric SeverePediatric
Typhoid fever#Ceftriaxone Pediatric, Quinolone Resistant PediatricCeftriaxone50-80mg/kg IV daily x 10-14 days (max 2g)Pediatric, Quinolone ResistantPediatric
Erysipelas#Ceftriaxone Inpatient AdultCeftriaxone1g (50mg/kg) IV once daily x 10 daysInpatientAdult
Acute cystitis#Ceftriaxone Inpatient AdultCeftriaxone1gm IV QDInpatientAdult
Cellulitis#Ceftriaxone Freshwater AdultCeftriaxone1g (50mg/kg) IV q24hrsFreshwaterAdult
Acute diarrhea#Ceftriaxone Pediatric travelers diarrhea PediatricCeftriaxone50mg/kg/day once daily x 3 daysPediatric travelers diarrheaPediatric
Traveler's diarrhea#Ceftriaxone Pediatric travelers diarrhea PediatricCeftriaxone50mg/kg/day once daily x 3 daysPediatric travelers diarrheaPediatric
Acute diarrhea#Ceftriaxone Pediatric travelers diarrhea PediatricCeftriaxone50mg/kg/day once daily x 3 daysPediatric travelers diarrheaPediatric
Neonatal conjunctivitis#Ceftriaxone Gonococcal conjunctivitis PediatricCeftriaxone25-50mg/kg IV or IM x1 (max 125mg)Gonococcal conjunctivitisPediatric
Diarrhea aguda#Ceftriaxone Pediatric travelers diarrhea PediatricCeftriaxone50mg/kg/day once daily x 3 daysPediatric travelers diarrheaPediatric
Pneumonia (main)#Cefuroxime Outpatient, Unhealthy AdultCefuroxime500 mg BIDOutpatient, UnhealthyAdult
Lyme disease#Cefuroxime Early Lyme disease, alternative, >13yo PediatricCefuroxime30mg/kg/day PO divided BID x 20 days (max 500mg/dose)Early Lyme disease, alternative, >13yoPediatric
Lyme disease#Cefuroxime Early Lyme disease, alternative AdultCefuroxime500mg PO BID x 20 daysEarly Lyme disease, alternativeAdult
Neisseria gonorrhoeae#Cefuroxime Uncomplicated urethral/cervical/rectal infection, alternative regimen AdultCefuroxime1000mg PO x 1Uncomplicated urethral/cervical/rectal infection, alternative regimenAdult
Sinusitis#Cefuroxime Alternative, not recommended per IDSA guidelines AdultCefuroxime250mg PO BID x 10 daysAlternative, not recommended per IDSA guidelinesAdult
Pharyngitis#Cefuroxime Pharyngitis/Tonsillitis, streptococcal AdultCefuroxime250mg PO bid x10 daysPharyngitis/Tonsillitis, streptococcalAdult
Acute otitis media#Cefuroxime Prior Month Treatment PediatricCefuroxime15mg/kg PO BID x7-10 daysPrior Month TreatmentPediatric
Pharyngitis#Cefuroxime 12+ yo, Pharyngitis/Tonsillitis, streptococcal PediatricCefuroxime250mg PO bid x10 days12+ yo, Pharyngitis/Tonsillitis, streptococcalPediatric
Sinusitis#Cefuroxime Alternative, not recommended per IDSA guidelines PediatricCefuroxime30mg/kg/day PO divided BID x 10 days (max 500mg/dose)Alternative, not recommended per IDSA guidelinesPediatric
Streptococcal pharyngitis#Cephalexin Penicillin Allergy (mild) AdultCephalexin20 mg per kg PO BID (maximum 500 mg per dose) x 10 daysPenicillin Allergy (mild)Adult
Impetigo#Cephalexin Oral therapy AdultCephalexin500mg (6.25mg/kg) PO q6hrs x 10 daysOral therapyAdult
Acute otitis media#Cephalexin Otitis Media PediatricCephalexin75-100mg/kg/day PO divided q12h x 10 days; Max: 4,000mg/24hOtitis MediaPediatric
Felon#Cephalexin Outpatient AdultCephalexin500mg PO q6hrs daily x 7 daysOutpatientAdult
Erysipelas#Cephalexin Alternative AdultCephalexin500mg (6.25mg/kg) PO q6hrs x 10 daysAlternativeAdult
Cellulitis#Cephalexin Outpatient AdultCephalexin500mg PO q6hrsOutpatientAdult
Pharyngitis#Cephalexin Streptococcal Pharyngitis (>1 Year) PediatricCephalexin40mg/kg/day PO divided q12h x 10 days; Max: 500mg/doseStreptococcal Pharyngitis (>1 Year)Pediatric
Impetigo#Cephalexin Pediatric Oral PediatricCephalexin25-50mg/kg/day PO divided q6-8h x 7-10 days (max 500mg/dose)Pediatric OralPediatric
Erysipelas#Cephalexin Pediatric PediatricCephalexin25-50mg/kg/day PO divided q6-8h x 10 days (max 500mg/dose)PediatricPediatric
Cellulitis#Cephalexin Pediatric Outpatient PediatricCephalexin25-50mg/kg/day PO divided q6-8h (max 500mg/dose)Pediatric OutpatientPediatric
Pyelonephritis#Cephalexin Pediatric Outpatient PediatricCephalexin25-50mg/kg/day PO divided q6-8h x 10-14 days (max 500mg/dose)Pediatric OutpatientPediatric
Endocarditis#Cephalexin Pediatric Dental Prophylaxis, mild PCN Allergy PediatricCephalexin50mg/kg PO (max 2g)Pediatric Dental Prophylaxis, mild PCN AllergyPediatric
Suppurative parotitis#Cephalexin Pediatric Outpatient PediatricCephalexin50mg/kg/day PO divided QID (max 500mg/dose)Pediatric OutpatientPediatric
Pyelonephritis#Cephalexin Outpatient AdultCephalexin500mg QID PO x 10-14 days (OR consider 1000mg BID)OutpatientAdult
Streptococcal pharyngitis#Cephalexin Pediatric PCN Allergy PediatricCephalexin20mg/kg PO BID x 10 days (max 500mg/dose)Pediatric PCN AllergyPediatric
Suppurative parotitis#Cephalexin Outpatient AdultCephalexin500mg (12.5mg/kg) PO four times dailyOutpatientAdult
Mastitis#Cephalexin First line alternative AdultCephalexin500mg PO q6hrsFirst line alternativeAdult
Acute cystitis#Cephalexin Outpatient, Women Uncomplicated AdultCephalexin250mg QID x 5dOutpatient, Women UncomplicatedAdult
Acute cystitis#Cephalexin Pediatric PediatricCephalexin25-50mg/kg/day PO divided q6-8h x 7-10 days (max 500mg/dose)PediatricPediatric
Acute allergic reaction#Cetirizine H1 antagonist; less sedating alternative AdultCetirizineAcute allergic reaction10mgH1 antagonist; less sedating alternativeIV/POAdult
Acute allergic reaction#Cetirizine H1 antagonist; less sedating alternative PediatricCetirizineAcute allergic reaction5-10mg IV (6-11yo); 2.5mg IV (6mo-5yo)H1 antagonist; less sedating alternativeIVPediatric
Bacterial conjunctivitis#Chloramphenicol Bacterial Conjunctivitis, Topical AdultChloramphenicol0.5% ophthalmic solution 1 drop QID for 7 daysBacterial Conjunctivitis, TopicalAdult
Rocky mountain spotted fever#Chloramphenicol Preferred in pregnancy AdultChloramphenicol50-100mg/kg/day div q6hrs (max 4g/day)Preferred in pregnancyAdult
Plague#Chloramphenicol Postexposure prophylaxis age over 2 only AdultChloramphenicol25mg/kg PO q6hrsPostexposure prophylaxis age over 2 onlyAdult
Tularemia#Chloramphenicol Active disease AdultChloramphenicol15mg/kg IV q6hrs x 14 daysActive diseaseAdult
Rocky mountain spotted fever#Chloramphenicol Pediatric Doxycycline Allergy PediatricChloramphenicol50-100mg/kg/day IV divided q6hrs (max 4g/day)Pediatric Doxycycline AllergyPediatric
Plague#Chloramphenicol Pediatric Prophylaxis PediatricChloramphenicol25mg/kg PO/IV q6hrs (max 4g/day); age >2 onlyPediatric ProphylaxisPediatric
Ethanol withdrawal#Chlordiazepoxide Outpatient taper (mild cases) AdultChlordiazepoxideEthanol withdrawal50 mg PO q8h x2 days, then 25 mg q8h x2 days, then 25 mg PRNOutpatient taper (mild cases)POAdult
Volume overload#Chlorothiazide IV thiazide for diuretic resistance AdultChlorothiazideVolume overload250-500mg IVIV thiazide for diuretic resistanceIVAdult
Cellulitis#Ciprofloxacin Freshwater AdultCiprofloxacin500mg PO q12hrs x 10 daysFreshwaterAdult
Otitis externa#Ciprofloxacin Topical (Ciprodex) AdultCiprofloxacin4 drops in affected ear BID x 7 daysTopical (Ciprodex)Adult
Anthrax#Ciprofloxacin Postexposure prophylaxis AdultCiprofloxacin500mg PO q12hrs x 60 daysPostexposure prophylaxisAdult
Pneumonia (main)#Ciprofloxacin VAP, High Risk AdultCiprofloxacin400mg IV q8hVAP, High RiskAdult
Acute necrotizing ulcerative gingivitis#Ciprofloxacin Penicillin Allergy AdultCiprofloxacin500mg twice dailyPenicillin AllergyAdult
Diabetic foot infection#Ciprofloxacin Moderate DFI AdultCiprofloxacin750mg PO q12hrs x 14 daysModerate DFIAdult
Discitis#Ciprofloxacin Inpatient Therapy AdultCiprofloxacin400mg IV three times dailyInpatient TherapyAdult
Anthrax#Ciprofloxacin Cutaneous anthrax, not systemically ill AdultCiprofloxacin500mg PO q12hrs x 60 daysCutaneous anthrax, not systemically illAdult
Diverticulitis#Ciprofloxacin Uncomplicated, Alternative AdultCiprofloxacin500mg PO BID x 5 daysUncomplicated, AlternativeAdult
Peritonitis#Ciprofloxacin Primary AdultCiprofloxacin400mg IV q12hrsPrimaryAdult
Peritonitis#Ciprofloxacin Allergy/Prior exposure AdultCiprofloxacin400mg IV q12hrsAllergy/Prior exposureAdult
Corneal abrasion#Ciprofloxacin No Contact Lens AdultCiprofloxacin0.3% ophthalmic solution 2 drops q6 hoursNo Contact LensAdult
Acute diarrhea#Ciprofloxacin Campylobacter AdultCiprofloxacin500mg PO BID x 5 daysCampylobacterAdult
Cellulitis#Ciprofloxacin Saltwater AdultCiprofloxacin400mg IV q12hrs x 10 daysSaltwaterAdult
Plague#Ciprofloxacin Postexposure prophylaxis AdultCiprofloxacin500mg (20mg/kg) PO q12hrsPostexposure prophylaxisAdult
Anthrax#Ciprofloxacin Inhalation or cutaneous with systemic illness; 1st line AdultCiprofloxacin400mg IV q12hrs x 60 daysInhalation or cutaneous with systemic illness; 1st lineAdult
Acute cystitis#Ciprofloxacin Inpatient AdultCiprofloxacin400mg IV q12hrInpatientAdult
Acute cystitis#Ciprofloxacin Men AdultCiprofloxacin500mg BID x10-14dMenAdult
Anthrax#Ciprofloxacin Pediatric postexposure prophylaxis PediatricCiprofloxacin15mg/kg PO q12hrs x 60 daysPediatric postexposure prophylaxisPediatric
Otitis externa#Ciprofloxacin Topical (Cipro HC) AdultCiprofloxacin3 drops in affected ear BID x 7 daysTopical (Cipro HC)Adult
Anthrax#Ciprofloxacin Pediatric inhalational/cutaneous, systemically ill; 1st line PediatricCiprofloxacin15mg/kg IV q12hrsPediatric inhalational/cutaneous, systemically ill; 1st linePediatric
Acute cystitis#Ciprofloxacin Outpatient, Women Complicated AdultCiprofloxacin500mg BID x10-14dOutpatient, Women ComplicatedAdult
Acute cystitis#Ciprofloxacin Outpatient, Women Uncomplicated AdultCiprofloxacin250mg BID x3dOutpatient, Women UncomplicatedAdult
Otitis externa#Ciprofloxacin Pediatric Topical PediatricCiprofloxacin3-4 drops in affected ear BID x 7 daysPediatric TopicalPediatric
Prostatitis#Ciprofloxacin Non-STD/Chronic AdultCiprofloxacin500mg PO q12hrs x 28 daysNon-STD/ChronicAdult
Pneumonia (main)#Ciprofloxacin HAP, High Risk AdultCiprofloxacin400mg q8hHAP, High RiskAdult
Plague#Ciprofloxacin Pediatric Active Disease/Prophylaxis PediatricCiprofloxacin15mg/kg PO q12hrs (max 500mg/dose)Pediatric Active Disease/ProphylaxisPediatric
Pyelonephritis#Ciprofloxacin Adult Inpatient AdultCiprofloxacin400mg IV q12hrAdult InpatientAdult
Tularemia#Ciprofloxacin Pediatric Active Disease/Prophylaxis PediatricCiprofloxacin15mg/kg PO/IV q12hrs x 10 days (max 500mg PO / 400mg IV)Pediatric Active Disease/ProphylaxisPediatric
Endocarditis#Ciprofloxacin MRSA Native Valve Endocarditis AdultCiprofloxacin1000mg/day PO in 2 doses or 800 mg/day IV in 2 dosesMRSA Native Valve EndocarditisAdult
Pyelonephritis#Ciprofloxacin Outpatient AdultCiprofloxacin500mg PO BID x7 daysOutpatientAdult
Diabetic foot infection#Ciprofloxacin Inpatient DFI AdultCiprofloxacin400mg IV q12hrsInpatient DFIAdult
Typhoid fever#Ciprofloxacin Quinolone Susceptible, Oral AdultCiprofloxacin500-750 mg PO q 12 hrs x 14 daysQuinolone Susceptible, OralAdult
Typhoid fever#Ciprofloxacin Quinolone Susceptible, Parenteral AdultCiprofloxacin400 mg IV q 12 hrs x 10 daysQuinolone Susceptible, ParenteralAdult
Mammalian bites#Ciprofloxacin Severe mammalian bite with Clindamycin AdultCiprofloxacin400mg IV q12hrsSevere mammalian bite with ClindamycinAdult
Mammalian bites#Ciprofloxacin Cat and dog bites with Clindamycin AdultCiprofloxacin500mg PO q12hrs x 7 daysCat and dog bites with ClindamycinAdult
Traveler's diarrhea#Ciprofloxacin Traveler's Diarrhea AdultCiprofloxacin750mg PO once daily x 1-3 daysTraveler's DiarrheaAdult
Salmonella#Ciprofloxacin Salmonella AdultCiprofloxacinAcute; 500-750mg PO q12h x 3-7 days; Extend treatment x 1 week if immunocompromised; Chronic Carrier; 750mg PO q12h x 1 monthSalmonellaAdult
Mammalian bites#Ciprofloxacin Human bites with Clindamycin AdultCiprofloxacin500mg PO q12hrs x 7 daysHuman bites with ClindamycinAdult
Ascending cholangitis#Ciprofloxacin Combined with metronidazole AdultCiprofloxacin400mg IV q12hrsCombined with metronidazoleAdult
Acute diarrhea#Ciprofloxacin Yersinia AdultCiprofloxacin500mg PO BID dailyYersiniaAdult
Chancroid#Ciprofloxacin Chancroid AdultCiprofloxacin500mg PO q12h x 3 daysChancroidAdult
Tularemia#Ciprofloxacin Active disease AdultCiprofloxacin400mg (15mg/kg) IV q12hrs x 10 daysActive diseaseAdult
Acute diarrhea#Ciprofloxacin Shigella AdultCiprofloxacin500mg PO BID x 5 daysShigellaAdult
Tularemia#Ciprofloxacin Postexposure prophylaxis AdultCiprofloxacin500mg PO q12hrs x 10 daysPostexposure prophylaxisAdult
Acute diarrhea#Ciprofloxacin Salmonella AdultCiprofloxacin500mg PO BID x 5 daysSalmonellaAdult
Plague#Ciprofloxacin Active disease AdultCiprofloxacin500mg (20mg/kg) PO q12hrs x 10 daysActive diseaseAdult
Neutropenic fever#Ciprofloxacin Outpatient AdultCiprofloxacin750mg PO q12hrsOutpatientAdult
Acute respiratory distress syndrome#Cisatracurium Neuromuscular blockade to prevent barotrauma/vent dyssynchrony AdultCisatracuriumAcute respiratory distress syndrome0.15mg/kg load, then 1-3mcg/kg/minNeuromuscular blockade to prevent barotrauma/vent dyssynchronyIVAdult
Pneumonia (main)#Clarithromycin Inpatient, CAP Non-ICU AdultClarithromycin500 mg BIDInpatient, CAP Non-ICUAdult
Pneumonia (main)#Clarithromycin Outpatient, Unhealthy AdultClarithromycin500 mg BID OR clarithromycin ER 1,000 mg dailyOutpatient, UnhealthyAdult
Streptococcal pharyngitis#Clarithromycin Pediatric PCN Allergy (severe) PediatricClarithromycin7.5mg/kg PO BID x 10 days (max 250mg/dose)Pediatric PCN Allergy (severe)Pediatric
Acute otitis media#Clarithromycin Penicillin Allergy PediatricClarithromycin7.5mg/kg PO BID x 10 daysPenicillin AllergyPediatric
Pertussis#Clarithromycin >1 month old PediatricClarithromycin>6 months: 7.5mg/kg PO BID x 7 days (max 500mg/dose)>1 month oldPediatric
Endocarditis#Clarithromycin Dental Procedure Prophylaxis AdultClarithromycin500mg (15mg/kg) PODental Procedure ProphylaxisAdult
Streptococcal pharyngitis#Clarithromycin Penicillin Allergy (anaphylaxis) AdultClarithromycin7.5 mg/kg/dose PO BID (maximum = 250 mg/dose) x 10 daysPenicillin Allergy (anaphylaxis)Adult
Pertussis#Clarithromycin Adults AdultClarithromycin500mg BID x7 daysAdultsAdult
Helicobacter pylori#Clarithromycin H. pylori infection PediatricClarithromycin20mg/kg/day PO divided BID x 7-14d; max 1000mg/dayH. pylori infectionPediatric
Pharyngitis#Clarithromycin Pharyngitis/tonsillitis, streptococcal PediatricClarithromycin>6mo: 15mg/kg/day PO divided q12h x 7-10dPharyngitis/tonsillitis, streptococcalPediatric
Helicobacter pylori#Clarithromycin H. pylori infection AdultClarithromycintriple treatment: 500mg PO q12hr x 7-14d; dual treatment: 500mg PO q8h x 14d (give with Omeprazole 40mg QD x 14d)H. pylori infectionAdult
COPD exacerbation#Clarithromycin Chronic bronchitis, acute bacterial exacerbation AdultClarithromycin1000mg ER PO q24 x 7d (with food, do not cut/crush/chew); Alt: 250-500mg PO q12h x 7-14dChronic bronchitis, acute bacterial exacerbationAdult
Mycobacterium avium complex#Clarithromycin Primary prophylaxis, HIV PediatricClarithromycin20mo-12yrs: 15mg/kg/day PO divided q12h (max 500mg/dose); >13yrs: 500mg PO q12hPrimary prophylaxis, HIVPediatric
Infectious tenosynovitis#Clarithromycin Mycobacteria AdultClarithromycin500mg PO twice dailyMycobacteriaAdult
Pneumonia (main)#Clarithromycin Outpatient, Healthy AdultClarithromycin500 mg BID or clarithromycin ER 1,000 mg dailyOutpatient, HealthyAdult
Mycobacterium avium complex#Clarithromycin Secondary prophylaxis, HIV PediatricClarithromycin20mo-12yrs: 15mg/kg/day PO divided q12h (max 500mg/dose, use with ethambutol); >13yrs: 500mg PO q12h (use with ethambutol)Secondary prophylaxis, HIVPediatric
Mycobacterium avium complex#Clarithromycin Secondary prophylaxis AdultClarithromycin500mg PO q12h (use with ethambutol)Secondary prophylaxisAdult
Mycobacterium avium complex#Clarithromycin Treatment, disseminated PediatricClarithromycin20mo-12yrs: 15-30mg/kg/day PO divided q12h (max 500mg/dose, use with ethambutol); >13yrs: 500mg PO q12h (use with ethambutol)Treatment, disseminatedPediatric
Mycobacterium avium complex#Clarithromycin Primary prophylaxis AdultClarithromycin500mg PO q12hPrimary prophylaxisAdult
Mycobacterium avium complex#Clarithromycin Treatment, disseminated AdultClarithromycin500mg PO q12h (use with ethambutol)Treatment, disseminatedAdult
Hypertensive emergency#Clevidipine Antihypertensive AdultClevidipineHypertensive emergency1-2 mg/hr, titrate by doubling q90 secAntihypertensiveIV dripAdult
Nontraumatic thoracic aortic dissection#Clevidipine Blood pressure control (vasodilator) after beta-blockade AdultClevidipineNontraumatic thoracic aortic dissection1-2mg/hr, double q90sec until approaching goalBlood pressure control (vasodilator) after beta-blockadeIVAdult
Stroke (main)#Clevidipine BP control in acute stroke AdultClevidipineStroke (main)1-2 mg/hr IV, double dose q2-5 min, max 21 mg/hrBP control in acute strokeIV dripAdult
Periorbital cellulitis#Clindamycin Outpatient PediatricClindamycin30 to 40 mg/kg per day in three to four equally divided doses, maximum 1.8 grams per dayOutpatientPediatric
Peritonsillar abscess#Clindamycin Outpatient AdultClindamycin300mg PO Q6hrs x7-10dOutpatientAdult
Cellulitis#Clindamycin Outpatient AdultClindamycin450mg PO TIDOutpatientAdult
Periorbital cellulitis#Clindamycin Outpatient AdultClindamycin300mg Q8HOutpatientAdult
Pneumonia (main)#Clindamycin ICU, Low Risk (PCN allergy) AdultClindamycin600mg IVICU, Low Risk (PCN allergy)Adult
Endocarditis#Clindamycin Pediatric Dental Prophylaxis, PCN Allergy PediatricClindamycin20mg/kg PO or IV (max 600mg)Pediatric Dental Prophylaxis, PCN AllergyPediatric
Cellulitis#Clindamycin Inpatient AdultClindamycin600mg IV q8hrsInpatientAdult
Sinusitis#Clindamycin Sinusitis PediatricClindamycin30-40mg/kg/day PO divided q8h x 10-14 days; Use with cefixime or cefpodoximeSinusitisPediatric
Diabetic foot infection#Clindamycin Moderate DFI AdultClindamycin450mg PO q8hrsModerate DFIAdult
Infectious tenosynovitis#Clindamycin Pediatrics PediatricClindamycin10mg/kg IV four times dailyPediatricsPediatric
Septic bursitis#Clindamycin Inpatient AdultClindamycin600 mg IV three times dailyInpatientAdult
Mammalian bites#Clindamycin Human bites alt AdultClindamycin450mg (5mg/kg) PO q8hrs x 7 daysHuman bites altAdult
Acute tetanus#Clindamycin Active tetanus alt AdultClindamycin600mg IV (7.5mg/kg) q6hrsActive tetanus altAdult
Felon#Clindamycin Outpatient AdultClindamycin450mg PO q8hrs x 7 daysOutpatientAdult
Endocarditis#Clindamycin Dental Procedure Prophylaxis AdultClindamycin600mg (20mg/kg) PO or IVDental Procedure ProphylaxisAdult
Babesiosis#Clindamycin Pediatric, with Quinine PediatricClindamycin20-40mg/kg/day PO divided TID x 7-10 days (max 600mg/dose)Pediatric, with QuininePediatric
Osteomyelitis#Clindamycin Sickle Cell Disease PediatricClindamycin10mg/kg IV PO four times dailySickle Cell DiseasePediatric
... further results

Drug-Specific Query: Epinephrine

All indications where Epinephrine is used:

 IndicationDoseContextRoutePopulation
Acute asthma exacerbation#Epinephrine Severe/life-threatening asthma AdultAcute asthma exacerbation0.01 mg/kg (1:1000) SC or IM q20min x3 (max 0.5 mg)Severe/life-threatening asthmaSC/IMAdult
Angioedema#Epinephrine Allergic/anaphylactic angioedema AdultAngioedema0.3 mg IMAllergic/anaphylactic angioedemaIMAdult
Croup#Epinephrine Moderate-severe croup with stridor at rest PediatricCroup0.5 mL/kg of 1:1000 nebulized (max 5 mL); or 0.05 mL/kg racemic epi 2.25% (max 0.5 mL)Moderate-severe croup with stridor at restNebulizedPediatric
Newborn resuscitation#Epinephrine Persistent bradycardia despite ventilation and compressions PediatricNewborn resuscitation0.01-0.03mg/kg (0.1-0.3mL/kg of 1:10,000) IV/IO q3-5minPersistent bradycardia despite ventilation and compressionsIV/IOPediatric
Pulseless arrest#Epinephrine Pulseless arrest (asystole/PEA) AdultPulseless arrest1 mg q3-5 minPulseless arrest (asystole/PEA)IV/IOAdult
Pulseless arrest#Epinephrine Pulseless arrest AdultPulseless arrest1 mg q3-5 minPulseless arrestIV/IOAdult
Sepsis (main)#Epinephrine 3rd line vasopressor AdultSepsis (main)1-20 mcg/min3rd line vasopressorIV dripAdult
Vasopressors#Epinephrine 2nd/3rd line vasopressor AdultVasopressors1-10 mcg/min (0.01-0.1 mcg/kg/min), max 0.5 mcg/kg/min2nd/3rd line vasopressorIV dripAdult
Vasopressors#Epinephrine Vasopressor/inotrope; consider in refractory shock AdultVasopressors0.01-0.5mcg/kg/minVasopressor/inotrope; consider in refractory shockIVAdult

Drug-Specific Query: Dexamethasone

All indications where Dexamethasone is used:

 IndicationDoseContextRoute
Acute asthma exacerbation (peds)#Dexamethasone Systemic corticosteroid; PO and IV equally effective PediatricAcute asthma exacerbation (peds)0.6mg/kg PO or IV (max 16mg); consider 2nd dose at 24-36hrSystemic corticosteroid; PO and IV equally effectivePO/IV
Acute asthma exacerbation#Dexamethasone Corticosteroid (preferred for adherence) AdultAcute asthma exacerbation0.6 mg/kg IV or PO (max 16 mg); 2nd dose 24hr laterCorticosteroid (preferred for adherence)IV/PO
Acute mountain sickness#Dexamethasone Moderate-severe AMS; symptomatic relief only, does not aid acclimatization AdultAcute mountain sickness4mg q6hrModerate-severe AMS; symptomatic relief only, does not aid acclimatizationPO
Chloramine#Dexamethasone Airway inflammation AdultChloramine0.6mg/kg IV or PO (max 16mg)Airway inflammationIV/PO
Croup#Dexamethasone Corticosteroid (1st line, any severity) PediatricCroup0.15-0.6 mg/kg PO/IV/IM (max 10 mg)Corticosteroid (1st line, any severity)PO/IV/IM
Headache#Dexamethasone Prevent headache recurrence 48-72h post-discharge AdultHeadache4-10 mg IV x1Prevent headache recurrence 48-72h post-dischargeIV
High altitude cerebral edema#Dexamethasone First-line pharmacotherapy; adjunct to immediate descent AdultHigh altitude cerebral edema8mg initially, then 4mg q6hrFirst-line pharmacotherapy; adjunct to immediate descentPO/IM/IV
Immune thrombocytopenic purpura#Dexamethasone First-line steroid regimen AdultImmune thrombocytopenic purpura40mg daily x 4 daysFirst-line steroid regimenIV/PO
Migraine headache#Dexamethasone Prevent headache recurrence 48-72h post-discharge AdultMigraine headache4-10 mg IV x1Prevent headache recurrence 48-72h post-dischargeIV
Migraine headache#Dexamethasone Prevent recurrence (48-72h post-discharge) AdultMigraine headache10 mg IVPrevent recurrence (48-72h post-discharge)IV
Peritonsillar abscess#Dexamethasone Adjunct steroid (pain/inflammation) AdultPeritonsillar abscess10 mgAdjunct steroid (pain/inflammation)IV/PO/IM
Sudden sensorineural hearing loss#Dexamethasone Salvage therapy or if systemic steroids contraindicated AdultSudden sensorineural hearing loss10mg/mL intratympanic injectionSalvage therapy or if systemic steroids contraindicatedIntratympanic
Thyroid storm#Dexamethasone Adrenal insufficiency treatment + T4→T3 blockade (alternative) AdultThyroid storm4 mg IV q6hAdrenal insufficiency treatment + T4→T3 blockade (alternative)IV

Drug-Specific Query: Insulin

All indications where Insulin is used:

 IndicationDoseContextRoute
Beta-blocker toxicity#Insulin High-dose insulin euglycemic therapy AdultBeta-blocker toxicity1 unit/kg IV bolus with D50, then 0.5-1 unit/kg/hr dripHigh-dose insulin euglycemic therapyIV/IV drip
Calcium channel blocker toxicity#Insulin High-dose insulin euglycemic therapy (best evidence) AdultCalcium channel blocker toxicity1 unit/kg IV bolus with D50, then 0.5-1 unit/kg/hr drip (max 2 units/kg/hr)High-dose insulin euglycemic therapy (best evidence)IV/IV drip
Diabetic ketoacidosis (peds)#Insulin DKA management PediatricDiabetic ketoacidosis (peds)0.1 units/kg/hr IV dripDKA managementIV drip
Diabetic ketoacidosis#Insulin IV insulin for moderate-severe DKA AdultDiabetic ketoacidosis0.1 units/kg/hr IV infusion (no bolus); reduce to 0.02-0.05 units/kg/hr when BG <250IV insulin for moderate-severe DKAIV drip
Diabetic ketoacidosis#Insulin SC insulin for mild DKA only AdultDiabetic ketoacidosis0.3 units/kg SC initial, then 0.1-0.2 units/kg SC q1-2hSC insulin for mild DKA onlySC

Indication-Specific Query: Hyperkalemia

All medications for Hyperkalemia:


Pages Converted (2026-03-20)

Page Entries Status
Rapid sequence intubation 14 ✅
Procedural sedation (via Template:Sedative agents) ~15 ✅
Status epilepticus (via Template:Seizure actively seizing management) ~15 ✅
Vasopressors (via Template:Vasopressor table) 9 ✅
Pulseless arrest 7 ✅
ACLS: Bradycardia 13 ✅
Anaphylaxis 9 ✅
Hypertensive emergency 10 ✅
Hyperkalemia 8 ✅
Eclampsia 3 ✅
Acute pain management 17 ✅
Diabetic ketoacidosis 3 ✅
Agitated or combative patient 7 ✅
ACLS: Tachycardia 5 ✅
Acute asthma exacerbation 13 ✅
Ethanol withdrawal 10 ✅
COPD exacerbation 3 ✅
Opioid toxicity 5 ✅
Thyroid storm 8 ✅
Migraine headache 6 ✅
Atrial fibrillation (main) 5 ✅
Adrenal crisis 2 ✅
Pulmonary embolism 4 ✅
Myxedema coma 2 ✅
ST-segment elevation myocardial infarction 8 ✅
Acetaminophen toxicity 3 ✅
Croup 2 ✅
Salicylate toxicity 2 ✅
Digoxin toxicity 6 ✅
Local anesthetic systemic toxicity 2 ✅
Calcium channel blocker toxicity 8 ✅
Beta-blocker toxicity 6 ✅
Angioedema 7 ✅
Serotonin syndrome 2 ✅
Malignant hyperthermia 2 ✅
Neuroleptic malignant syndrome 4 ✅
TOTAL ~235 36 pages
Retrieved from "https://www.wikem.org/w/index.php?title=User:Danbot/MedicationDose_Sandbox&oldid=386897"